CompletedPhase 3NCT04340128

Efficacy of Intra-lesional Injections of Glucantime Once a Week or Twice a Week in the Treatment of Anthroponotic Cutaneous Leishmaniasis (ACL)

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Tehran University of Medical Sciences
Principal Investigator
Alireza Khatami, MD MSPH
Center for Research & Training in Skin Diseases & Leprosy, Tehran University of Medical Sciences
Intervention
Meglumine antimoniate(drug)
Eligibility
9-70 years · All sexes
Timeline
2007 – 2007

Study locations (1)

Collaborators

Mashad University of Medical Sciences · Kerman University of Medical Sciences

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04340128 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis →

← Back to all trials